Literature DB >> 7776910

Isolation of HIV-1 from experimentally contaminated multidose local anaesthetic vials.

J D Druce1, S A Locarnini, C J Birch.   

Abstract

OBJECTIVE: To investigate the hypothesis that HIV can be transmitted via contamination of multidose vials of local anaesthetic solution through reuse of needles and syringes. DESIGN AND
SETTING: Laboratory study. (1) By experiments with multidose vials and disposable needles and syringes, we identified a sequence of events in which HIV could contaminate the anaesthetic solution. (2) Three anaesthetic solutions were contaminated with a laboratory strain of HIV and tested by viral culture and p24 enzyme immunoassay one, two and four hours later to see how long the virus remained active.
RESULTS: (1) Needles and syringes retained small volumes of fluid after use (mean, 25 microL; in syringe alone, mean 16 microL) which could be transferred to multidose vials of local anaesthetic. (2) 10 mL of anaesthetic solution contaminated with 8 microL of HIV-infected solution (equivalent to 1% infected lymphocytes in vivo) contained active virus one hour later. In some settings, HIV could be isolated four hours after exposure.
CONCLUSION: When inadvertently contaminated with HIV, multidose solutions represent a potential source of transmissible virus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7776910     DOI: 10.5694/j.1326-5377.1995.tb138507.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  2 in total

1.  Uncovering high rates of unsafe injection equipment reuse in rural Cameroon: validation of a survey instrument that probes for specific misconceptions.

Authors:  Mbah P Okwen; Bedes Y Ngem; Fozao A Alomba; Mireille V Capo; Savanna R Reid; Ebong C Ewang
Journal:  Harm Reduct J       Date:  2011-02-07

2.  Successful management of tendinopathy with injections of the MMP-inhibitor aprotinin.

Authors:  John Orchard; Andrew Massey; Richard Brown; Adéline Cardon-Dunbar; Jamie Hofmann
Journal:  Clin Orthop Relat Res       Date:  2008-05-01       Impact factor: 4.176

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.